Miller Anestesia

411. Warnes CA, Liberthson R, Danielson GK, et al: Task

force 1: The changing profile of congenital heart

disease in adult life. J Am Coll Cardiol 37:1170–

1175, 2001.

412. Perloff JK, Warnes CA: Challenges posed by adults

with repaired congenital heart disease. Circulation

103:2637–2643, 2001.

413. Niwa K, Perloff JK, Bhuta SM, et al: Structural

abnormalities of great arterial walls in congenital

heart disease: Light and electron microscopic analy-

ses. Circulation 103:393–400, 2001.

414. Forbess JM, Visconti KJ, Hancock-Friesen C, et al:

Neurodevelopmental outcome after congenital

heart surgery: Results from an institutional registry.

Circulation 106:I95–I102, 2002.

415. Bellinger DC, Wypij D, duDuplessis AJ, et al: Neu-

rodevelopmental status at eight years in children

with dextro-transposition of the great arteries: The

Boston Circulatory Arrest Trial. J Thorac Cardio-

vasc Surg 126:1385–1396, 2003.

416. Bellinger DC, Wypij D, Kuban KC, et al: Develo-

pmental and neurological status of children

at 4 years of age after heart surgery with

hypothermic circulatory arrest or low-flow car-

diopulmonary bypass. Circulation 100:526–532,

1999.

417. Visconti KJ, Bichell DP, Jonas RA, et al: Develop-

mental outcome after surgical versus interventional

closure of secundum atrial septal defect in children.

Circulation 100:II145–II150, 1999.

418. Wernovsky G, Stiles KM, Gauvreau K, et al: Cogni-

tive development after the Fontan operation. Circu-

lation 102:883–889, 2000.

419. Chassot PG, Bettex DA: Anesthesia and adult con-

genital heart disease. J Cardiothorac Vasc Anesth

20:414–437, 2006.

420. Lovell AT: Anaesthetic implications of grown-up

congenital heart disease. Br J Anaesth 93:129–139,

2004.

421. Landzberg MJ, Murphy DJ Jr, Davidson WR Jr, et al:

Task force 4: Organization of delivery systems for

adults with congenital heart disease. J Am Coll

Cardiol 37:1187–1193, 2001.

422. Ammash N, Warnes CA: Cerebrovascular events in

adult patients with cyanotic congenital heart

disease. J Am Coll Cardiol 28:768–772, 1996.

423. Diller GP, Dimopoulos K, Okonko D, et al: Exercise

intolerance in adult congenital heart disease: Com-

parative severity, correlates, and prognostic implica-

tion. Circulation 112:828–835, 2005.

424. Veldtman GR, Connolly HM, Grogan M, et al:

Outcomes of pregnancy in women with tetralogy of

Fallot. J Am Coll Cardiol 44:174–180, 2004.

425. Khairy P, Ouyang DW, Fernandes SM, et al: Preg-

nancy outcomes in women with congenital heart

disease. Circulation 113:517–524, 2006.

426. Gillinov AM, Wolf RK: Surgical ablation of atrial

fibrillation. Prog Cardiovasc Dis 48:169–177, 2005.

427. Cox JL, Ad N, Palazzo T, et al: Current status of the

Maze procedure for the treatment of atrial fibrilla-

tion. Semin Thorac Cardiovasc Surg 12:15–19,

2000.

428. Prasad SM, Maniar HS, Camillo CJ, et al: The Cox-

Maze III procedure for atrial fibrillation: Long-term

efficacy in patients undergoing lone versus conco-

mitant procedures. J Thorac Cardiovasc Surg

126:1822–1828, 2003.

429. Arcidi JM Jr, Doty DB, Millar RC: The Maze proce-

dure: The LDS Hospital experience. Semin Thorac

Cardiovasc Surg 12:38–43, 2000.

430. McCarthy PM, Gillinov AM, Castle L, et al: The

Cox-Maze procedure: The Cleveland Clinic expe-

rience. Semin Thorac Cardiovasc Surg 12:25–29,

2000.

431. Schaff HV, Dearani JA, Daly RC, et al: Cox-Maze

procedure for atrial fibrillation: Mayo Clinic expe-

rience. Semin Thorac Cardiovasc Surg 12:30–37,

2000.

432. Gaita F, Riccardi R, Calo L, et al: Atrial mapping and

radiofrequency catheter ablation in patients with

idiopathic atrial fibrillation: Electrophysiological

findings and ablation results. Circulation 97:2136–

2145, 1998.

433. Cox JL: The role of surgical intervention in the

management of atrial fibrillation. Tex Heart Inst J

31:257–265, 2004.

434. Roy CL, Minor MA, Brookhart MA, et al: Does this

patient with a pericardial effusion have cardiac tam-

ponade? JAMA 297:1810–1818, 2007.

435. Shabetai R: Pericardial effusion: Haemodynamic

spectrum. Heart 90:255–256, 2004.

436. Kussmaul A: Über schwielige Mediastino-Perikar-

ditis und den paradoxen Puls. Berl Klin Wochens-

chr 10:433–435, 1873.

437. Maisch B, Seferovic PM, Ristic AD, et al: Guidelines

on the diagnosis and management of pericardial

diseases executive summary. The Task Force on the

Diagnosis and Management of Pericardial Diseases

of the European Society of Cardiology. Eur Heart J

25:587–610, 2004.

438. Spodick DH: Acute cardiac tamponade. N Engl J

Med 349:684–690, 2003.

439. Reddy PS, Curtiss EI: Cardiac tamponade. Cardiol

Clin 8:627–637, 1990.

440. Pepi M, Muratori M: Echocardiography in the diag-

nosis and management of pericardial disease. J Car-

diovasc Med (Hagerstown) 7:533–544, 2006.

441. Soler-SolerJ,Sagrista-SauledaJ,Permanyer-Miralda

G: Management of pericardial effusion. Heart

86:235–240, 2001.

442. Longo SR, Campbell DB: Management of cardio-

thoracic surgical emergencies. In Hensley FA,

Martin DE, Gravlee GP (eds): A Practical Approach

to Cardiac Anesthesia, 4th ed. Philadelphia, Lippin-

cott Williams & Wilkins, 2008, pp 474–488.

443. Aye T, Milne B: Ketamine anesthesia for pericardial

window in a patient with pericardial tamponade

and severe COPD. Can J Anaesth 49:283–286,

2002.

444. Osterberg L, Vagelos R, Atwood JE: Case presenta-

tion and review: Constrictive pericarditis. West J

Med 169:232–239, 1998.

445. Little WC, Freeman GL: Pericardial disease. Circu-

lation 113:1622–1632, 2006.

446. Myers RB, Spodick DH: Constrictive pericarditis:

Clinical and pathophysiologic characteristics. Am

Heart J 138:219–232, 1999.

447. Ling LH, Oh JK, Schaff HV, et al: Constrictive peri-

carditis in the modern era: Evolving clinical spec-

trum and impact on outcome after pericardiectomy.

Circulation 100:1380–1386, 1999.

448. Degiannis E, Bowley DM, Westaby S: Penetrating

cardiac injury. Ann R Coll Surg Engl 87:61–63, 2005.

449. Saadia R, Levy RD, Degiannis E, et al: Penetrating

cardiac injuries: Clinical classification and manage-

ment strategy. Br J Surg 81:1572–1575, 1994.

450. Parasramka SV, Ghotkar S, Kendall J, Fabri BM: Use

of transoesophageal echocardiography in manage-

ment of penetrating cardiac injury. Eur J Echocar-

diogr 9:563–564, 2008.

451. Lin PH, Bush RL, Zhou W, et al: Endovascular

treatment of traumatic thoracic aortic injury—

should this be the new standard of treatment? J Vasc

Surg 43(Suppl A)22A–29A, 2006.

452. Jamieson WR, Janusz MT, Gudas VM, et al: Trau-

matic rupture of the thoracic aorta: Third decade of

experience. Am J Surg 183:571–575, 2002.

453. Nzewi O, Slight RD, Zamvar V: Management of

blunt thoracic aortic injury. Eur J Vasc Endovasc

Surg 31:18–27, 2006.

454. Smith MD, Cassidy JM, Souther S, et al: Transe-

sophageal echocardiography in the diagnosis of

traumatic rupture of the aorta. N Engl J Med

332:356–362, 1995.

455. Vignon P, Gueret P, Vedrinne JM, et al: Role of tran-

sesophageal echocardiography in the diagnosis and

management of traumatic aortic disruption. Circu-

lation 92:2959–2968, 1995.

456. Fabian TC, Richardson JD, Croce MA, et al: Pros-

pective study of blunt aortic injury: Multicenter

Trial of the American Association for the Surgery

of Trauma. J Trauma 42:374–380, 1997.

457. von Oppell UO, Dunne TT, De Groot MK, et al:

Traumatic aortic rupture: Twenty-year metaanalysis

of mortality and risk of paraplegia. Ann Thorac

Surg 58:585–593, 1994.

458. Gammie JS, Shah AS, Hattler BG, et al: Traumatic

aortic rupture: Diagnosis and management. Ann

Thorac Surg 66:1295–1300, 1998.

459. Fabian TC, Davis KA, Gavant ML, et al: Prospective

study of blunt aortic injury: Helical CT is diagnostic

and antihypertensive therapy reduces rupture. Ann

Surg 227:666–676, 1998.

460. Kahn RA, Moskowitz DM: Endovascular aortic

repair. J Cardiothorac Vasc Anesth 16:218–233, 2002.

461. Moskowitz DM, Kahn RA, Marin ML, et al: Intrao-

perative rupture of an abdominal aortic aneurysm

during an endovascular stent-graft procedure. Can

J Anaesth 46:887–890, 1999.

462. Orihashi K, Matsuura Y, Sueda T, et al: Echocardio-

graphy-assisted surgery in transaortic endovascular

stent grafting: Role of transesophageal echocardio-

graphy. J Thorac Cardiovasc Surg 120:672–678,

2000.

463. Konstadt SN, Reich DL, Quintana C, et al: The

ascending aorta: How much does transesophageal

echocardiography see? Anesth Analg 78:240–244,

1994.

464. Bansal RC, Chandrasekaran K, Ayala K, et al: Fre-

quency and explanation of false negative diagnosis

of aortic dissection by aortography and transe-

sophageal echocardiography. J Am Coll Cardiol

25:1393–1401, 1995.

465. Morris RJ, KuretuML, Grunewald KE, et al: Surgical

treatment of interventional coronary angiographic

accidents. Angiology 50:789–795, 1999.

466. Joe RR, Chen LQ: Anesthesia in the cardiac cathe-

terization lab. Anesthesiol Clin North Am 21:639–

651, 2003.

467. Bashore TM, Bates ER, Berger PB, et al: American

College of Cardiology/Society for Cardiac Angio-

graphy and Interventions Clinical Expert Consen-

sus Document on cardiac catheterization laboratory

standards. A report of the American College of Car-

diology Task Force on Clinical Expert Consensus

Documents. J Am Coll Cardiol 37:2170–2214,

2001.

468. Hata M, Shiono M, Sezai A, et al: Outcome of emer-

gency conventional coronary surgery for acute

coronary syndrome due to left main coronary

disease. Ann Thorac Cardiovasc Surg 12:28–31,

2006.

469. Reddy K, Jaggar S, Gillbe C: The anaesthetist and

the cardiac catheterisation laboratory. Anaesthesia

61:1175–1186, 2006.

470. Bettex DA, Lachat M, Pfammatter T, et al: To

compare general, epidural and local anaesthesia for

endovascular aneurysm repair (EVAR). Eur J Vasc

Endovasc Surg 21:179–184, 2001.

471. Fogoros RN. In: Electrophysiologic Testing, 4th ed.

Malden, MA, Blackwell Futura, 2006.

472. Bardy GH, Lee KL, Mark DB, et al: Amiodarone or

an implantable cardioverter-defibrillator for con-

gestive heart failure. N Engl J Med 352:225–237,

2005.

473. Jarcho JA: Resynchronizing ventricular contraction

in heart failure. N Engl J Med 352:1594–1597,

2005.

474. Cleland JG, Daubert JC, Erdmann E, et al: The effect

of cardiac resynchronization on morbidity and

mortality in heart failure. N Engl J Med 352:1539–

1549, 2005.

475. Hakanson E, Svedjeholm R, Vanhanen I: Physiolo-

gic aspects in postoperative cardiac patients. Ann

Thorac Surg 59:S12–S14, 1995.

476. Gillies M, Bellomo R, Doolan L, et al: Bench-to-

bedside review: Inotropic drug therapy after adult

cardiac surgery—a systematic literature review. Crit

Care 9:266–279, 2005.

477. Rao V, Ivanov J, Weisel RD, et al: Predictors of low

cardiac output syndrome after coronary artery

bypass. J Thorac Cardiovasc Surg 112:38–51, 1996.

478. Maganti MD, Rao V, Borger MA, et al: Predictors of

low cardiac output syndrome after isolated aortic

valve surgery. Circulation 112:I448–I452, 2005.

479. Labriola C, Siro-Brigiani M, Carrata F, et al: Hemo-

dynamic effects of levosimendan in patients with

low-output heart failure after cardiac surgery. Int J

Clin Pharmacol Ther 42:204–211, 2004.

Anestesia para los procedimientos de cirugía cardíaca

1739

Sección IV

Anestesia por subespecialidades en el adulto